Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viscotoxins are small, cationic, cysteine-rich peptides (thionins) derived from mistletoe (Viscum album) that exhibit cytotoxicity towards various cell types, including tumor cells. They disrupt plasma membrane integrity by binding to and inserting into membranes containing negatively charged phospholipids, resulting in pore formation, increased membrane permeability, and subsequent necrotic cell death. This membranolytic activity is concentration-dependent and can lead to ion channel formation and oxidative stress. While this action underlies their cytotoxic (anticancer and antimicrobial) effects, selectivity for tumor cells is limited, raising concerns about potential toxicity to normal tissues[1][3][5][7].
Direct membrane binding and disruption (pore formation, "carpet" or "toroidal" pore model[1][3][5]); Induction of cell lysis and necrosis via loss of plasma membrane integrity; Possible ion channel formation in anionic membranes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viscotoxin.